QSA's Week in BioPharma (#2, 2025)
Canada signs $32M drug access deal; MPs debate Pharmacare delays; Updated CIHR grant data published.
Start Date: 2025-01-11
End Date: 2025-01-17
Top Headlines
Main Stories
Canada and New Brunswick Sign $32 Million Agreement for Rare Disease Drugs
Health Canada announced a bilateral agreement with New Brunswick, investing over $32 million to improve access to drugs for rare diseases. This agreement aims to support the availability of Poteligeo, Oxlumo, Epkinly, and Welireg, targeting various rare conditions. The deal is part of the National Strategy for Drugs for Rare Diseases, and New Brunswick will collaborate with other provinces to enhance diagnostics and screening. The initiative is expected to make treatments more affordable and accessible, impacting those with rare diseases significantly.
Sources: ['Announcements: www.canada.ca', 'Announcements: www.canada.ca']
